Eli Lilly
LLY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 1 day ago • LLY
Huge News for Eli Lilly Stock Investors!The Motley Fool • 1 day ago • LLY
Why Is Eli Lilly Stock Crashing and Is It a Buying Opportunity?Seeking Alpha • 2 days ago • LLY
Eli Lilly: Obesity Drug Development To Go Beyond That Of ZepboundZacks Investment Research • 3 days ago • LLY
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItSeeking Alpha • 3 days ago • LLY
Eli Lilly and Company (LLY) BofA Securities 2025 Health Care Conference Call TranscriptCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.